All In Biotech

Free tool

FAERS Monitor: Humulin 70/30 Pen

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming BLA 019717 or its brand name (Humulin 70/30 Pen, Insulin Recombinant Human, Insulin Susp Isophane Recombinant Human). Reports on generic versions are filed under their own applications.

Reports

16,106

Serious

10,597

66% of reports

Hospitalization

6,042

Death reported

1,307

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • blood glucose increased3,691
  • blood glucose decreased1,150
  • drug ineffective1,038
  • incorrect dose administered753
  • hypoglycaemia689
  • nausea641
  • dyspnoea600
  • weight decreased594
  • visual impairment573
  • diarrhoea552
  • fall548
  • dizziness505
  • fatigue477
  • malaise472
  • vomiting462

Reports by year received

View as table
YearReports
2004503
2005543
2006765
2007442
2008314
2009394
2010348
2011354
2012351
2013409
2014686
20152,902
2016616
2017457
2018745
2019764
2020744
2021806
2022956
2023874
2024866
2025779
2026488

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,038,053 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
blood glucose decreasedSignal1,15032.030.333,774
blood glucose increasedSignal3,69126.125.388,020
hypoglycaemiaSignal68918.817.511,458
visual impairmentSignal5736.15.62,420
incorrect dose administeredSignal7534.34.01,932
weight decreasedSignal5942.82.6684
fallSignal5482.22.0342
malaise4721.41.356
dyspnoea6001.41.365
dizziness5051.31.240
vomiting4621.31.229
diarrhoea5521.11.07
nausea6411.11.02
drug ineffective1,0381.01.01
fatigue4770.80.725

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.